---
figid: PMC9455056__cancers-14-04113-g004
pmcid: PMC9455056
image_filename: cancers-14-04113-g004.jpg
figure_link: /pmc/articles/PMC9455056/figure/cancers-14-04113-f004/
number: Figure 4
figure_title: ''
caption: 'Purine and pyrimidine biosynthesis via de novo and salvage pathways. Purine
  pathway: ADSL, adenylosuccinate lyase; APRT, adenine phosphoribosyltransferase;
  ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and IMP cyclohydrolase;
  GART, phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase,
  phosphoribosylaminoimidazole synthetase; Glu, glutamate; Gln, glutamine; HPRT, hypoxanthine-guanine
  phosphoribosyltransferase; IMPDH, inosine monophosphate dehydrogenase; PRPS1, phosphoribosyl
  pyrophosphate synthetase 1; PAICS, phosphoribosyl aminoimidazole carboxylase and
  phosphoribosyl aminoimidazole succinocarboxamide synthase; PFAS, phosphoribosyl
  formylglycinamidine synthase; PPAT, phosphoribosyl pyrophosphate amidotransferase.
  Pyrimidine pathway: CAD, carbamoyl phosphate synthase, aspartate transcarbamoylase,
  and dihydroorotase; CoQ ubiquinone; CoQH2, ubiquinol; DHODH, dihydroorotate dehydrogenase;
  UCK, uridine-cytidine kinase; UMPS, UMP synthetase. Enzymes highlighted in red are
  MYCN targets.'
article_title: MYCN and Metabolic Reprogramming in Neuroblastoma.
citation: Mohit Bansal, et al. Cancers (Basel). 2022 Sep;14(17):4113.
year: '2022'

doi: 10.3390/cancers14174113
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI

keywords:
- cancer metabolism
- metabolic reprogramming
- MYCN
- neuroblastoma
- pediatric cancer

---
